Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MIRA PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Common Stock | 382K | $371K | $0.97 | May 21, 2024 | Direct |
Telomir Pharmaceuticals, Inc. | CEO & Chairman, Director | Incentive Stock Options (right to buy) | 1.96M | Aug 27, 2024 | Direct | ||
MIRA PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Incentive Stock Options (right to buy) | 629K | May 28, 2024 | Direct | ||
MIRA PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Incentive Stock Option (right to buy) | 250K | Mar 26, 2024 | Direct | ||
MIRA PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Stock Options | 150K | Aug 17, 2023 | Direct | ||
Telomir Pharmaceuticals, Inc. | CEO & Chairman, Director | Common Stock | 30K | Aug 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Aug 27, 2024 | 1 | $0 | 4 | Aug 29, 2024 | CEO & Chairman, Director |
TELO | Telomir Pharmaceuticals, Inc. | Aug 8, 2024 | 0 | $0 | 3 | Aug 15, 2024 | CEO & Chairman, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | May 28, 2024 | 1 | $0 | 4 | May 30, 2024 | Chief Executive Officer, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | May 21, 2024 | 8 | $8.18K | 4 | May 22, 2024 | Chief Executive Officer, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Mar 26, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Chief Executive Officer, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 17, 2023 | 1 | $0 | 4 | Aug 21, 2023 | CEO and Director, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 2, 2023 | 0 | $0 | 3 | Aug 2, 2023 | Chief Executive Officer, Director |